Bellevue Asset Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Bellevue Asset Management's RGEN Position: Q1 2026 in Review
Bellevue Asset Management sold out of Repligen (RGEN) in Q1 2026, closing a stake of 22 shares — an estimated $3.6K sold.
Bellevue Asset Management first reported a position in RGEN in Q3 2025 and held it in 2 quarters. The position peaked at $3.6K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Bellevue Asset Management reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
- Bellevue Asset Management sold 22 Repligen shares in Q1 2026, an estimated $3.6K.
- Bellevue Asset Management first reported a position in Repligen in Q3 2025 and held it in 2 quarters.
- Bellevue Asset Management's Repligen position peaked at $3.6K in Q4 2025.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Bellevue Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.